Literature DB >> 24870839

[FGF23 and skeletal metabolism].

Toshimi Michigami1.   

Abstract

FGF23 is an endocrine FGF produced by osteocytes, which increases excretion of phosphate and suppresses the production of 1,25 (OH) 2D. Excessive action of FGF23 causes various forms of hypophosphatemic rickets/osteomalacia, while the loss of function of FGF23 results in the condition called familial hyperphosphatemic tumoral calcinosis. 1,25 (OH) 2D stimulates the production of FGF23, and the interaction between FGF23 and 1,25 (OH) 2D plays a central role in mineral homeostasis. In addition to the its roles in mineral homeostasis, recent studies have suggested the direct action of FGF23 on osteoblasts and chondrocytes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24870839     DOI: CliCa1406879884

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  2 in total

1.  Specific ablation of mouse Fam20C in cells expressing type I collagen leads to skeletal defects and hypophosphatemia.

Authors:  Peihong Liu; Su Ma; Hua Zhang; Chao Liu; Yongbo Lu; Li Chen; Chunlin Qin
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

2.  Twist1-Haploinsufficiency Selectively Enhances the Osteoskeletal Capacity of Mesoderm-Derived Parietal Bone Through Downregulation of Fgf23.

Authors:  Natalina Quarto; Siny Shailendra; Nathaniel P Meyer; Siddharth Menon; Andrea Renda; Michael T Longaker
Journal:  Front Physiol       Date:  2018-10-15       Impact factor: 4.566

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.